Delivery Order SPE2DB24D3015-SPE2DB26FFWUU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Livalo 1 mg tablets (90-count packages) with a ceiling value of $4,675.27. This competitive award, executed as a firm fixed-price delivery order with no set-aside designation, represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's Corporate Office location...
- The Defense Logistics Agency awarded a delivery order valued at $3,953.53 to AmerisourceBergen Drug Corp for the supply of Livalo 4 mg tablets (90-count units), with an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order under a non-set-aside competitive procurement. The awardee, AmerisourceBergen Drug Corp, is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and will fulfill this order from its corporate office location in the...
- The Defense Logistics Agency awarded a delivery order valued at $22,629.65 to AmerisourceBergen Drug Corp for the supply of Livalo 1 mg tablets (90-count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order is issued as a child contract under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,336.06 for 90 tablets of Livalo 2 mg on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $2,835.51 to AmerisourceBergen Drug Corp for 90 tablets of Livalo 2 mg, a pharmaceutical product used to manage cholesterol levels. The award was issued on July 14, 2025, with an ultimate completion date of July 15, 2025, and was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city....
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564134891 LIVALO 1 MG TABLET 90S. The contract has a ceiling value of $1,262.90 and a period of performance through April 2, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver these pharmaceutical products from its Corporate Office location in Conshohocken, Pennsylvania...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LIVALO 2 MG TABLET 90S. The contract has a ceiling value of $1,273.59 and runs through August 6, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The Defense Logistics Agency awarded a $5,342 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90 tablets of the pharmaceutical LIVALO 4 MG. As the prime contractor, Amerisourcebergen will deliver the specified pharmaceutical products to a location in Conshohocken, Pennsylvania by August 10, 2023 under the terms of the contract. No additional details were provided regarding major subcontractors or the use of any set aside designations. The Defense Logistics Agency...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of LIVALO 2 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $2,977.16 and a completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $545 to Amerisourcebergen Drug Corporation to supply 90 tablets of the pharmaceutical Livalo 2 mg. The order was placed under an existing Amerisourcebergen contract vehicle to fulfill requirements for the Department of Defense's medical supply needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period in late August 2023. No subcontractors...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB26FFWUUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Livalo 4 mg tablets (90-count) valued at $1,680.16. This firm fixed-price delivery order, which concludes on October 30, 2025, was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial federal contracting presence as a critical vendor for military and veteran healthcare systems. The company's extensive portfolio with the Defense Logistics Agency encompasses a broad range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Livalo, a statin-class cardiovascular medication, exemplifies the company's role in supplying essential medications to support Defense Health Agency and broader Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/29/25 |